Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Estrogen provides neuroprotective effects in ovariectomized rats

April 8, 1999

Low-dose clozapine reduces drug-induced psychosis in Parkinson's disease

April 8, 1999

Small-molecule N-type Ca2+ channel blockers designed by Neurex/Parke-Davis group

April 7, 1999

Identification and neuroprotective activity of GV-224029 discussed at ACS meeting

April 7, 1999

Selective NMDA antagonists in the Lilly pipeline

April 7, 1999

Glycine-site NMDA antagonist is safe and well tolerated in stroke patients

April 7, 1999

Sanofi's new CRF antagonists: preparation, use and pharmaceutical compositions

April 7, 1999

Meiji Milk presents new therapeutics for dementia that stimulate neurite growth

April 7, 1999

ProScript receives SBIR grant for novel stroke treatment

April 7, 1999

Licensing opportunity from Yeda: iron chelators for treatment of neurologic disorders

April 7, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...